時(shí)一添 袁風(fēng)紅 鄒耀紅


【摘要】 目的:探討分析原發(fā)性腎上腺淋巴瘤(primary adrenal lymphoma)的臨床特征、診斷、治療及預(yù)后,提高對(duì)該疾病的認(rèn)識(shí)。方法:回顧性分析4例經(jīng)病理證實(shí)的原發(fā)性腎上腺淋巴瘤臨床特征并復(fù)習(xí)相關(guān)文獻(xiàn)。患者均以發(fā)熱為主要首發(fā)癥狀,CT提示腎上腺占位,依靠穿刺明確診斷。結(jié)果:4例均為非霍奇金淋巴瘤,其中1例為T細(xì)胞來(lái)源,于確診后1個(gè)月死亡,剩余3例為B細(xì)胞來(lái)源,均予R-CHOP方案化療,2017年3月隨訪2例無(wú)瘤存活,1例化療中。結(jié)論:原發(fā)性腎上腺淋巴瘤臨床缺乏特異性表現(xiàn),通常由CT等影像學(xué)檢查發(fā)現(xiàn)腎上腺腫物,經(jīng)由穿刺活檢病理確診,大部分為非霍奇金淋巴瘤,多聯(lián)合化療為首選治療方案,病理類型影響疾病預(yù)后。
【關(guān)鍵詞】 腎上腺; 淋巴瘤; 非霍奇
doi:10.14033/j.cnki.cfmr.2017.18.084 文獻(xiàn)標(biāo)識(shí)碼 B 文章編號(hào) 1674-6805(2017)18-0161-04
Clinical Features Analysis of Four Cases of Primary Adrenal Lymphoma and Review of Literature/SHI Yi-tian,YUAN Feng-hong,ZOU Yao-hong.//Chinese and Foreign Medical Research,2017,15(18):161-164
【Abstract】 Objective:To discuss the clinical features,diagnosis,therapy and prognosis of primary adrenal lymphoma(PAL) in order to enhance the understanding of this disease.Method:The clinical data of 4 patients with pathologically proven as PAL were retrospectively analyzed,considering literatures review.Fever was the first symptom of all 4 patients,occupying lesions in adrenal gland were discovered by computed tomography(CT) and diagnosed by needle biopsy.Result:Pathology revealed all 4 cases had non-Hodgkins lymphoma,1 case was T-cell type,who died within 1 month,the other 3 cases were B cell type,received R-CHOP chemotherapy,all the 3 patients were followed up in March 2017,2 patients were tumor-free survival,1 patient was currently undergoing chemotherapy.Conclusion:PAL has no special clinical manifestations,it is usually discovered by CT imaging findings of adrenal masses,diagnosed by pathological examination though needle biopsy.A majority type of the patients are NHL,the principal treatment is adjuvant combination chemotherapy,pathologic type affects the prognosis of the disease.
【Key words】 Adrenal glands; Lymphoma; Non-Hodgkin
First-authors address:The Affiliated Wuxi Peoples Hospital of Nanjing Medical University,Wuxi 214023,China
目前國(guó)內(nèi)外關(guān)于原發(fā)性腎上腺淋巴瘤(PAL)的報(bào)道少見(jiàn)[1],人們對(duì)該疾病的臨床癥狀、病例特點(diǎn)、診治及預(yù)后認(rèn)識(shí)有限,臨床上很容易誤診,筆者回顧性分析近年來(lái)筆者所在科收治的4例原發(fā)性腎上腺淋巴瘤患者,并綜合文獻(xiàn)復(fù)習(xí)以提高對(duì)該疾病的認(rèn)識(shí)。
1 病例介紹
病例1:男,62歲,因“反復(fù)發(fā)熱1個(gè)月”于2015年1月6日收治筆者所在科,外院體溫最高39.2 ℃,多于下午出現(xiàn),夜間達(dá)到發(fā)熱高峰,無(wú)特殊陽(yáng)性癥狀,院外予哌拉西林舒巴坦、左氧氟沙星抗感染治療無(wú)效,查體無(wú)陽(yáng)性體征,入院后查胸部+腹部CT示雙側(cè)腎上腺塊團(tuán)影,左側(cè)較大,大小約66 mm×35 mm,增強(qiáng)后輕中度強(qiáng)化(圖1),縱隔及后腹膜未見(jiàn)腫大淋巴結(jié);淺表彩超未見(jiàn)腫大淋巴結(jié);骨穿:感染性髓像;血常規(guī):WBC 2.85×109/L,Hb 110 g/L,血小板63×109/L,CRP 9 mg/L,血沉15 mm/h,肝腎功能、電解質(zhì)正常,LDH>21 500 U/L;T-spot.TB陽(yáng)性,A孔74,B孔40;查皮質(zhì)醇、ACTH、腎素血管緊張素醛固酮、尿香草基苦杏酸(VMA)、性激素等均在正常范圍,甲狀腺功能:FT3 2.05 pmol/L(3.8~6 pmol/L),F(xiàn)T4、TSH正常;CT引導(dǎo)下腎上腺穿刺活檢,病理提示非霍奇金淋巴瘤(T細(xì)胞來(lái)源),但因患者一般情況持續(xù)惡化,未予化療,于1個(gè)月后死亡。endprint